News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

King Pharmaceuticals®, Inc. Announces Tilade Inhaler to be Discontinued


5/2/2008 11:01:46 AM

San Francisco, Calif. -- King Pharmaceuticals announces the discontinuation of Tilade Inhaler (nedocromil sodium inhalation aerosol). The drug is being discontinued for a variety of reasons, including the company's inability to identify a qualified manufacturer for a chlorofluorocarbon propellant inhaler. TILADE(R) will remain available through pharmacies and wholesalers until current supplies are depleted.

To view a letter from the company, please visit: http://www.fda.gov/cder/drug/shortages/Tilade_DHCPApril2008.pdf

Contact: Suvarna Bhatt at sbhatt@biospace.com.


Read at BioSpace.com


comments powered by Disqus
   
Asthma

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES